Web16 feb. 2024 · 1 Background: To determine whether the efficacy of a hypofractionated (H) schedule is no worse than a conventional (C) schedule in men with low-risk prostate cancer. Methods: From April 2006 to December 2009, one thousand one hundred fifteen men with low-risk prostate cancer (clinical stage T1-2a, Gleason ≤ 6, PSA < 10) were randomly … Web2 mrt. 2024 · DOI: 10.1200/JCO.2024.39.6_suppl.60 Journal of Clinical Oncology - published online before print March 2, 2024 Longitudinal predictive ability of mapping algorithms: Secondary analysis of NRG Oncology/RTOG 0415.
Hypofractionation for prostate cancer: tested and proven
Web19 feb. 2024 · DOI: 10.1200/JCO.2024.38.6_suppl.55 Journal of Clinical Oncology - published online before print February 19, 2024 A methodological comparison of mapping algorithms to obtain health utilities derived using cross-sectional and longitudinal data: Secondary analysis of NRG/RTOG 0415. Web1 jun. 2024 · The purpose of this study is to define dose–volume predictors for late gastrointestinal and genitourinary (GI and GU) toxicities after HRT in the multi-center NRG Oncology/RTOG 0415 low-risk prostate cancer trial (N = 521). Material/methods: Treatment in the studied HRT arm was delivered as 70 Gy at 2.5 Gy/fraction with 3D-CRT/IMRT (N … pytan
Radiation technique and outcomes following moderately …
Web16 jan. 2024 · NRG Oncology 0415 supports moderate hypofractionation as a reasonable option for low-risk disease, however, the majority of these patients may be better served … Web1 jul. 2024 · Methodological Comparison of Mapping the Expanded Prostate Cancer Index Composite to EuroQoL-5D-3L Using Cross-Sectional and Longitudinal Data: Secondary Analysis of NRG/RTOG 0415 JCO Clinical Cancer Informatics Skip to main content Log In submission complete icon Submit envelope E-Alerts cart Cart OpenAthens/Shibboleth » Web4 apr. 2016 · The purpose of NRG Oncology RTOG 0415 was to determine whether the efficacy of a hypofractionated treatment schedule was not worse than a conventional … pytaller